Verve Therapeutics
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $216M
Investors
- 14
About Verve Therapeutics
Founded in 2018 and based in Massachusetts, US, Verve Therapeutics, Inc. is a biotechnology company that develops therapies for cardiovascular diseases (CVD) with gene editing medicines. The company treats CVD that collectively refers to diseases of the heart and the blood, diagnosed as atherosclerotic cardiovascular disease (ASCVD) or cardiomyopathy, among others. The firm was founded by Burt Adelman, J. Keith Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho. As of 2021, the company is chaired by Sekar Kathiresan as CEO. In 2020, Verve Therapeutics, Inc. In 2021, Verve Therapeutics, Inc. In June 2021, Verve Therapeutics, Inc.04 million shares at USD 19 per share on the Nasdaq under the ticker symbol, VERV. Verve Therapeutics develops medicines that involve making edits in adult cells, which are not passed onto the offspring. Verve’s lead product candidate is Verve-101- a single-course in vivo liver gene-editing treatment for patients with HeFH (Heterozygous Familial Hypercholesterolemia). Verve-101 utilizes LNP-mediated delivery and targets the PCSK9 and ANGPTL3 genes that are responsible for lowering blood lipids. Verve Therapeutics, Inc.
Who invested in Verve Therapeutics
14 investors across 3 rounds
See all investors in Verve Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Verve Therapeutics
Who invested in Verve Therapeutics?
Verve Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Verve Therapeutics raised?
Verve Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Verve Therapeutics last raise money?
Verve Therapeutics's most recent round on record is a Series B, in Jan 2021.
What does Verve Therapeutics do?
Founded in 2018 and based in Massachusetts, US, Verve Therapeutics, Inc.
Where is Verve Therapeutics headquartered?
Verve Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Verve Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Verve Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Verve Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.